Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cyclin-dependent kinase 5 regulates degranulation in human eosinophils.

Odemuyiwa SO, Ilarraza R, Davoine F, Logan MR, Shayeganpour A, Wu Y, Majaesic C, Adamko DJ, Moqbel R, Lacy P.

Immunology. 2015 Apr;144(4):641-8. doi: 10.1111/imm.12416.

2.

An essential role for Rab27a GTPase in eosinophil exocytosis.

Kim JD, Willetts L, Ochkur S, Srivastava N, Hamburg R, Shayeganpour A, Seabra MC, Lee JJ, Moqbel R, Lacy P.

J Leukoc Biol. 2013 Dec;94(6):1265-74. doi: 10.1189/jlb.0812431. Epub 2013 Aug 28.

3.

Encapsulation of P-glycoprotein inhibitors by polymeric micelles can reduce their pharmacokinetic interactions with doxorubicin.

Binkhathlan Z, Shayeganpour A, Brocks DR, Lavasanifar A.

Eur J Pharm Biopharm. 2012 May;81(1):142-8. doi: 10.1016/j.ejpb.2012.02.003. Epub 2012 Feb 14.

PMID:
22361031
4.

Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles.

Hamdy S, Haddadi A, Shayeganpour A, Samuel J, Lavasanifar A.

Pharm Res. 2011 Sep;28(9):2288-301. doi: 10.1007/s11095-011-0459-9. Epub 2011 May 11.

PMID:
21560020
5.

The immunosuppressive activity of polymeric micellar formulation of cyclosporine A: in vitro and in vivo studies.

Hamdy S, Haddadi A, Shayeganpour A, Alshamsan A, Montazeri Aliabadi H, Lavasanifar A.

AAPS J. 2011 Jun;13(2):159-68. doi: 10.1208/s12248-011-9259-8. Epub 2011 Feb 19.

6.

Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity.

Zhang Y, El-Sikhry H, Chaudhary KR, Batchu SN, Shayeganpour A, Jukar TO, Bradbury JA, Graves JP, DeGraff LM, Myers P, Rouse DC, Foley J, Nyska A, Zeldin DC, Seubert JM.

Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H37-46. doi: 10.1152/ajpheart.00983.2008. Epub 2009 May 8.

7.

Effects of intestinal constituents and lipids on intestinal formation and pharmacokinetics of desethylamiodarone formed from amiodarone.

Shayeganpour A, Hamdy DA, Brocks DR.

J Pharm Pharmacol. 2008 Dec;60(12):1625-32. doi: 10.1211/jpp/60.12.0008.

PMID:
19000367
8.

The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat.

Shayeganpour A, Korashy H, Patel JP, El-Kadi AO, Brocks DR.

Int J Pharm. 2008 Sep 1;361(1-2):78-86. doi: 10.1016/j.ijpharm.2008.05.019. Epub 2008 May 27.

PMID:
18599227
9.
10.

The influence of hyperlipoproteinemia on in vitro distribution of amiodarone and desethylamiodarone in human and rat plasma.

Shayeganpour A, Lee SD, Wasan KM, Brocks DR.

Pharm Res. 2007 Apr;24(4):672-8. Epub 2007 Feb 15.

PMID:
17372694
11.

High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin.

Ma Z, Shayeganpour A, Brocks DR, Lavasanifar A, Samuel J.

Biomed Chromatogr. 2007 May;21(5):546-52.

PMID:
17340565
12.

Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines.

Korashy HM, Shayeganpour A, Brocks DR, El-Kadi AO.

Toxicol Sci. 2007 May;97(1):32-43. Epub 2007 Feb 5.

PMID:
17283379
13.
14.
15.

Development of a sensitive and specific liquid chromatography/mass spectrometry method for the quantification of cucurbitacin I (JSI-124) in rat plasma.

Molavi O, Shayeganpour A, Somayaji V, Hamdy S, Brocks DR, Lavasanifar A, Kwon GS, Samuel J.

J Pharm Pharm Sci. 2006;9(2):158-64.

16.
18.

Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models.

Shayeganpour A, Jun AS, Brocks DR.

Biopharm Drug Dispos. 2005 Sep;26(6):249-57.

PMID:
15968713
19.

Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats.

Kalitsky-Szirtes J, Shayeganpour A, Brocks DR, Piquette-Miller M.

Drug Metab Dispos. 2004 Jan;32(1):20-7.

PMID:
14709616
20.

Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam.

Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M.

J Clin Pharm Ther. 2001 Oct;26(5):363-7.

PMID:
11679026

Supplemental Content

Loading ...
Support Center